New antiepileptic drugs, cost-efficacy analysis
Objective: to optimize pharmacotherapy in patients with epilepsy and to evaluate the clinical and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine, topiramate, and oxcarbazepine.Patients and methods. The study enrolled 134 patients (women, 69.03%;...
Saved in:
| Main Authors: | P. N. Vlasov, N. V. Orekhova, T. I. Konovalova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2014-01-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/226 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EPIDEMIOLOGIC RESEARCH ON EPILEPSY IN MINSK
by: T. V. Dokukina, et al.
Published: (2015-03-01) -
A description of sodium valproate, lamotrigine and levetiracetam consumption in the Western Cape public sector
by: Nicole Keuler, et al.
Published: (2022-06-01) -
Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation
by: P. N. Vlasov
Published: (2017-11-01) -
Endocrine Function and Antiepileptic Drugs
by: J Gordon Millichap
Published: (1999-03-01) -
Movement Disorders Induced by Antiepileptic Drugs
by: J Gordon Millichap
Published: (2007-02-01)